117 related articles for article (PubMed ID: 14698606)
41. Neuron-astrocyte omnidirectional signaling in neurological health and disease.
Pathak D; Sriram K
Front Mol Neurosci; 2023; 16():1169320. PubMed ID: 37363320
[TBL] [Abstract][Full Text] [Related]
42. Oxidative Stress as a Potential Mechanism Underlying Membrane Hyperexcitability in Neurodegenerative Diseases.
Pardillo-Díaz R; Pérez-García P; Castro C; Nunez-Abades P; Carrascal L
Antioxidants (Basel); 2022 Aug; 11(8):. PubMed ID: 36009230
[TBL] [Abstract][Full Text] [Related]
43. Medicinal Cannabis and Central Nervous System Disorders.
Ortiz YT; McMahon LR; Wilkerson JL
Front Pharmacol; 2022; 13():881810. PubMed ID: 35529444
[TBL] [Abstract][Full Text] [Related]
44. Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets.
Shibuya K; Otani R; Suzuki YI; Kuwabara S; Kiernan MC
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455429
[TBL] [Abstract][Full Text] [Related]
45. Interaction of Mitochondrial Calcium and ROS in Neurodegeneration.
Baev AY; Vinokurov AY; Novikova IN; Dremin VV; Potapova EV; Abramov AY
Cells; 2022 Feb; 11(4):. PubMed ID: 35203354
[TBL] [Abstract][Full Text] [Related]
46. Senolytics: A Novel Strategy for Neuroprotection in ALS?
Maximova A; Werry EL; Kassiou M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769512
[TBL] [Abstract][Full Text] [Related]
47. Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies.
Hemerková P; Vališ M
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33809730
[TBL] [Abstract][Full Text] [Related]
48. A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases.
Silvestro S; Sindona C; Bramanti P; Mazzon E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804658
[TBL] [Abstract][Full Text] [Related]
49. Retrospective Observational Study and Analysis of Two Different Photobiomodulation Therapy Protocols Combined with Rehabilitation Therapy as Therapeutic Interventions for Canine Degenerative Myelopathy.
Miller LA; Torraca DG; De Taboada L
Photobiomodul Photomed Laser Surg; 2020 Apr; 38(4):195-205. PubMed ID: 32301669
[No Abstract] [Full Text] [Related]
50. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology.
Zhao C; Devlin AC; Chouhan AK; Selvaraj BT; Stavrou M; Burr K; Brivio V; He X; Mehta AR; Story D; Shaw CE; Dando O; Hardingham GE; Miles GB; Chandran S
Glia; 2020 May; 68(5):1046-1064. PubMed ID: 31841614
[TBL] [Abstract][Full Text] [Related]
51. The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives.
García JC; Bustos RH
Brain Sci; 2018 Dec; 8(12):. PubMed ID: 30551598
[TBL] [Abstract][Full Text] [Related]
52. SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis.
Wallis N; Lau CL; Farg MA; Atkin JD; Beart PM; O'Shea RD
Neurochem Res; 2018 Jan; 43(1):166-179. PubMed ID: 28861673
[TBL] [Abstract][Full Text] [Related]
53. Generation and validation of novel adeno-associated viral vectors for the analysis of Ca
Norante RP; Massimino ML; Lorenzon P; De Mario A; Peggion C; Vicario M; Albiero M; Sorgato MC; Lopreiato R; Bertoli A
Sci Rep; 2017 Jul; 7(1):6521. PubMed ID: 28747684
[TBL] [Abstract][Full Text] [Related]
54. Extraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons.
Silva-Hucha S; Hernández RG; Benítez-Temiño B; Pastor ÁM; de la Cruz RR; Morcuende S
PLoS One; 2017; 12(6):e0178616. PubMed ID: 28570669
[TBL] [Abstract][Full Text] [Related]
55. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.
Paloczi J; Varga ZV; Hasko G; Pacher P
Antioxid Redox Signal; 2018 Jul; 29(1):75-108. PubMed ID: 28497982
[TBL] [Abstract][Full Text] [Related]
56. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
Diana A; Pillai R; Bongioanni P; O'Keeffe AG; Miller RG; Moore DH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006049. PubMed ID: 28067943
[TBL] [Abstract][Full Text] [Related]
57. Comparative Analysis of VOCs in Exhaled Breath of Amyotrophic Lateral Sclerosis and Cervical Spondylotic Myelopathy Patients.
Wang C; Li M; Jiang H; Tong H; Feng Y; Wang Y; Pi X; Guo L; Nie M; Feng H; Li E
Sci Rep; 2016 May; 6():26120. PubMed ID: 27212435
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol: A Focus on Several Neurodegenerative Diseases.
Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
[TBL] [Abstract][Full Text] [Related]
59. Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation.
Jaiswal MK
Mol Cell Ther; 2014; 2():26. PubMed ID: 26056593
[TBL] [Abstract][Full Text] [Related]
60. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
